Myeloperoxidase polymorphisms in brain infarction. Association with infarct size and functional outcome

Atherosclerosis

Volumn 167, Issue 2, 2003, Pages 223-230

  Hoy, Aline ^a   Leininger Muller, Brigitte ^a   Poirier, Odette ^b   Siest, Gérard ^a   Gautier, Marion ^b   Elbaz, Alexis ^b   Amarenco, Pierre ^c   Visvikis, Sophie ^a  

^a Centre de Medecine Preventive   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Brain infarction; Functional outcome; Myeloperoxidase; Polymorphism

Indexed keywords

CHOLESTEROL; MYELOPEROXIDASE;

ADULT; AGED; ALLELE; ARTICLE; ATHEROSCLEROSIS; BRAIN INFARCTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME POLYMORPHISM; FEMALE; GENDER; GENOTYPE; HUMAN; HYBRIDIZATION; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

EID: 0038464980     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00041-2     Document Type: Article

References (30)

1. Elbaz A., Amarenco P. Genetic susceptibility and ischaemic stroke. Curr. Opin. Neurol. 12:1999;47.
2. Chan P.H. Role Oxidants Ischemic Brain Damage Stroke. 27:1996;1124.
3. Kochanek P.M., Hallenbeck J.M. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke. 23:1992;1367.
4. Barone F.C., Hillegas L.M., Price W.J., et al. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J. Neurosci. Res. 29:(3):1991;336.
5. Nichols B.A., Bainton D.F. Differentiation of human monocytes in bone marrow and blood. Sequential formation of two granule populations. Lab. Invest. 29:1973;27.
6. Nagra R.M., Becher B., Tourtelotte W.W., et al. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J. Neuroimmunol. 78:(1-2):1997;97.
7. Klebanoff S.J. Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes. Science. 169:(950):1970;1095.
8. London S.J., Lehman T.A., Taylor J.A. Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res. 57:1997;5001.
9. Kristal B., Shurtz-Swirski R., Manaster J., et al. Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension. Am. J. Hypertens. 11:(8 Pt 1):1998;921.
10. Daugherty A., Rateri D.L., Dunn J., Heinecke J.W. Myeloperoxidase: A catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94:1994;437.
11. Hazen S.L., Heinecke J.W. 3-chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation is markedly elevated in low density lipoproteins isolated from human atherosclerostic intima. J. Clin. Invest. 99:(9):1997;2075.
12. Heinecke J.W. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis. 141:1998;1.
13. Piedrafita F.J., Molander R.B., Vansant G., Orlova E.A., Pfahl M., Reynolds W.F. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J. Biol. Chem. 271:(24):1996;14412.
14. Reynolds W.F., Rhees J., Maciejewski D., Paladino T., Sieburg H., Maki R.A., Masliah E. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Exp. Neurol. 155:(1):1999;31.
15. Reynolds W.F., Chang E., Douer D., Ball E.D., Kanda V. An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia. Blood. 90:(7):1997;2730.
16. Falke P., Elneihoum A.M., Ohlsson K. Leukocyte activation: relation to cardiovascular mortality after cerebrovascular ischemia. Cerebrovasc. Dis. 10:(2):2000;97.
17. Elbaz A., Poirier O., Canaple S., Chédru F., Cambien F., Amarenco P. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction. Blood. 95:(2):2000;586.
18. Rankin J. Cerebral vascular accidents in patients over the age of 60, I: general considerations. Scott. Med. J. 2:1957;127.
19. Breslow N.E., Day N.E. The analysis of case-control studies. 1980;IARC Scientific Publications, Lyon, France.
20. SAS institute Inc: SAS user's guide statistics. Cary, NC, 1990.
21. Sackett D.L. Bias in analytical research. J. Chron. Dis. 32:1979;51.
22. Kantarci O.H., Atkinson E.J., Hebrink D.D., McMurray C.T., Weinshenker B.G. Association of a myeloperoxidase promoter polymorphism with multiple sclerosis. J. Neuroimmunol. 105:(2):2000;189.
23. Jolivalt C., Leininger-Muller B., Bertrand P., Herber R., Christen Y., Siest G. Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids. Free Radic. Biol. Med. 28:2000;129.
24. Walder C.E., Green S.P., Darbonne W.C., et al. Ischemic stroke injury is reduced in mice lacking functional NADPH oxidase. Stroke. 28:1997;2252.
25. Ito D., Murata M., Watanabe K., Yoshida T., Saito I., Tanahashi N., Fukuuchi Y. C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the japanese population. Stroke. 31:(4):2000;936.
26. Matsuo Y., Onodera H., Shiga Y., Nakamura M., Ninomiya M., Kihara T., Kogure K. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke. 25:1994;1469.
27. Pozzilli C., Lenzi G.L., Argentino C., Bozzao L., Rasura M., Giubilei F., Fieschi C. Peripheral white blood cell count in cerebral ischaemic infarction. Acta Neurol. Scand. 71:1985;396.
28. Silvestrini M., Pietroiusti A., Troisi E., et al. Leukocyte count and aggregation during the evolution of cerebral ischaemic injury. Cerebrovasc. Dis. 8:1998;305.
29. Dik M.G., Deeg D.J.H., Bouter L.M., Corder E.H., Kok A., Jonker C. Stroke and apolipoprotein Eε4 are independent risk factors for cognitive decline. Stroke. 31:2000;2431.
30. Reynolds W.F., Hiltunen M., Pirskanen M., et al. MPO and APOEε4 polymorphisms interact to increase risk for AD in Finnish males. Neurology. 55:2000;1284.